Expert Opinion on Pharmacotherapy

Evaluation of the injection force dynamics of a modified prefilled insulin pen
pp. 2217-2222(6)
Authors: Rissler, J; Jørgensen, C; Rye Hansen, M; Hansen, N-A

Safety, simplicity and convenience of a modified prefilled insulin pen
pp. 2223-2232(10)
Authors: Sommavilla, B; Jørgensen, C; Jensen, KH

Pharmacotherapy of chronic viral hepatitis and hepatocellular carcinoma
pp. 2233-2245(13)
Authors: Feitelson, Mark A; Clayton, Marcia M; Reis, Helena MGPV; Wu, Guoyi; Lu, Eva Ping

Pharmacotherapy of large B-cell lymphoma
pp. 2247-2258(12)
Authors: Escalón, Maricer P; Lossos, Izidore S

Pharmacotherapy of relapsed metastatic testicular cancer
pp. 2259-2272(14)
Authors: Kollmannsberger, C; Honecker, F; Bokemeyer, C

An update on treatment strategies for acromegaly
pp. 2273-2280(8)
Author: Katznelson, Laurence

Medical management of thyroid dysfunction in pregnancy and the postpartum
pp. 2281-2293(13)
Authors: Okosieme, Onyebuchi E; Marx, Helen; Lazarus, John H

The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?
pp. 2295-2303(9)
Authors: Rizzo, Manfredi; Christ, Emanuel R; Rini, Giovam Battista; Spinas, Giatgen A; Berneis, Kaspar

Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease
pp. 2305-2316(12)
Authors: Li, Minghui; Sun, Kai; Welniak, Lisbeth A; Murphy, William J

Non-contraceptive benefits of oral contraceptives
pp. 2317-2325(9)
Authors: Huber, Johannes C; Bentz, Eva-Katrin; Ott, Johannes; Tempfer, Clemens B

Idebenone in Friedreich's ataxia
pp. 2327-2337(11)
Authors: Tonon, Caterina; Lodi, Raffaele

Anidulafungin: a drug evaluation of a new echinocandin
pp. 2339-2348(10)
Authors: Joseph, Jomy M; Kim, Rose; Reboli, Annette C

Reassessment of enfuvirtide's role in the management of HIV-1 infection
pp. 2349-2362(14)
Authors: Marr, Patricia; Walmsley, Sharon

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
pp. 2363-2375(13)
Authors: Barragan, Patricia; Podzamczer, Daniel

Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus
pp. 2377-2382(6)
Authors: Velásquez-Mieyer, Pedro A; Neira, Claudia P

Therapeutic potential of icatibant (HOE-140, JE-049)
pp. 2383-2390(8)
Authors: Cruden, Nicholas LM; Newby, David E

Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload
pp. 2391-2402(12)
Authors: Cappellini, MD; Taher, A